It was reported to boston scientific corporation that a spaceoar vue device was implanted during a placement procedure performed on (b)(6) 2022.Additionally, fiducial markers were placed.On (b)(6) 2023 the patient presented with fever and rectal pain.The patient received a urine culture which was negative for infections.Therefore, the physician decided to perform a computerized tomography (ct) scan.However, over that weekend, the patient went to the emergency department (ed) and was admitted due to increased pain and fevers.The patient's white blood cell (wbc) count was elevated at 12,000 to 14,000.The blood culture turned positive for b.Fragilis.A ct scan done by the ed apparently showed fluid around the spaceoar vue implant.In the physician's assessment, the scan did not look like an abscess, instead, it looked like clear fluid.He also did not see any spaceoar vue in the rectal wall.The patient was treated with intravenous (iv) antibiotics since his admission to the ed, and he was reported to be improving.The patient's pain and fever were down, although his white blood cell count was reported to had not yet decreased.It was also reported that the plan is to keep the patient under antibiotics treatment and avoid a drainage for now.If it is necessary, the physician will attempt a drainage himself.It was also planned to get a magnetic resonance imaging (mri) without contrast, to determine if the hydrogel is in the rectum.Boston scientific has been unable to obtain additional details, despite good faith efforts (gfes).
|